SYNAURA is dedicated to advancing synthetic biology research and development through cutting-edge synthetic biology technologies, applying these innovations to large-scale production. Currently, SYNAURA's product pipeline encompasses over 20 offerings, with Human Milk Oligosaccharides (HMOs) serving as its flagship product. Concurrently, the company is developing additional pipelines spanning diverse sectors including biomedicine, sustainable agriculture, and health foods.